KMT2A and acute myeloid leukemia: By contrast, MLL wild-type AML cells (HL-60 and U-937) were substantially resistant to A-485 (Additional file 1: Fig. S4A) with no significant changes in proliferation, apoptosis and cell cycle upon treatment (Additional file 1: Fig. S4B–D).